Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery.
Yiu
P
P
Cardiothoracic Surgical Unit and Departments of Intensive Care and Clinical Pharmacology, University College and Middlesex Hospitals, London, United Kingdom.
Robin
J
J
Pattison
C W
CW
D000368:Aged; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D005260:Female; D006162:Guanylate Cyclase / Q000037:antagonists & inhibitors*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000188:drug therapy* / Q000201:enzymology / Q000209:etiology* / Q000503:physiopathology; D007262:Infusions, Intravenous; D008297:Male; D008751:Methylene Blue / Q000627:therapeutic use*; D009638:Norepinephrine / Q000627:therapeutic use; D013997:Time Factors; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D014662:Vasoconstrictor Agents; D006162:Guanylate Cyclase; D008751:Methylene Blue; D009638:Norepinephrine